Health In Tech reaffirms FY2026 sales guidance of $45M-$50M
Health In Tech (NASDAQ: HIT) affirms its FY2026 sales outlook at $45.000M-$50.000M, unchanged from prior guidance and versus a $46.813M estimate.
Health In Tech (NASDAQ: HIT ) affirms FY2026 sales outlook from $45.000 million-$50.000 million to $45.000 million-$50.000 million vs $46.813 million estimate.